| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.19 | 1e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |